FDA inspection
Hybio Pharmaceutical Co. Ltd (Site 1): FDA inspection ending Jun 26, 2015
FDA inspection 936556 · Voluntary Action Indicated (VAI) · Shenzhen
Key facts
| Inspection ID | 936556 |
|---|---|
| Firm | Hybio Pharmaceutical Co. Ltd (Site 1) |
| FEI number | 3010165930 |
| Address | 37 Keji C, Str 2nd, Shenzhen Hi-Tech Ind |
| City | Shenzhen |
| Country | China |
| Fiscal year | 2015 |
| Inspection end date | Jun 26, 2015 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data